Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1785 1
1786 1
1845 1
1846 1
1848 1
1849 3
1853 1
1854 1
1860 3
1861 1
1866 1
1870 1
1871 1
1874 1
1875 1
1878 1
1881 2
1883 1
1884 1
1886 1
1887 1
1889 1
1894 1
1895 2
1907 1
1908 3
1909 1
1910 2
1911 3
1913 2
1914 15
1916 2
1917 1
1918 5
1919 1
1921 1
1922 1
1923 3
1924 5
1925 4
1926 5
1927 4
1928 3
1929 1
1931 3
1932 2
1933 6
1934 3
1935 1
1936 1
1938 2
1940 4
1942 1
1944 2
1945 21
1946 44
1947 59
1948 61
1949 36
1950 85
1951 56
1952 56
1953 41
1954 44
1955 61
1956 28
1957 35
1958 31
1959 39
1960 21
1961 42
1962 49
1963 72
1964 91
1965 72
1966 76
1967 66
1968 70
1969 57
1970 69
1971 63
1972 72
1973 69
1974 81
1975 109
1976 100
1977 100
1978 63
1979 104
1980 83
1981 84
1982 129
1983 119
1984 128
1985 133
1986 131
1987 146
1988 188
1989 219
1990 238
1991 223
1992 209
1993 224
1994 225
1995 273
1996 239
1997 193
1998 223
1999 230
2000 242
2001 228
2002 223
2003 225
2004 218
2005 254
2006 275
2007 304
2008 313
2009 366
2010 367
2011 429
2012 539
2013 516
2014 573
2015 562
2016 639
2017 666
2018 773
2019 878
2020 981
2021 993
2022 1174
2023 1207
2024 622

Text availability

Article attribute

Article type

Publication date

Search Results

18,106 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: tribromphenolate
Page 1
A review on bismuth-based nanocomposites for energy and environmental applications.
Sivasubramanian P, Chang JH, Nagendran S, Dong CD, Shkir M, Kumar M. Sivasubramanian P, et al. Chemosphere. 2022 Nov;307(Pt 1):135652. doi: 10.1016/j.chemosphere.2022.135652. Epub 2022 Jul 8. Chemosphere. 2022. PMID: 35817189 Review.
These review papers are the vital points for the students, this report guides them to the research papers which focus on the impressive development in the area of bismuth and similar nanostructures. The purpose of the present review is to discuss the various synthesis rout …
These review papers are the vital points for the students, this report guides them to the research papers which focus on the impressive deve …
Bismuth therapy in gastrointestinal diseases.
Gorbach SL. Gorbach SL. Gastroenterology. 1990 Sep;99(3):863-75. doi: 10.1016/0016-5085(90)90983-8. Gastroenterology. 1990. PMID: 2199292 Review.
An epidemic of neurological toxicity was reported in France in the 1970's with prolonged bismuth treatment, usually bismuth subgallate and subnitrate. Such toxicity has been rare with bismuth subsalicylate and colloidal bismuth subcitrate. ...These fin …
An epidemic of neurological toxicity was reported in France in the 1970's with prolonged bismuth treatment, usually bismuth su …
Bismuth iodoform paraffin paste: a review.
Crossland GJ, Bath AP. Crossland GJ, et al. J Laryngol Otol. 2011 Sep;125(9):891-5. doi: 10.1017/S0022215111001599. Epub 2011 Jul 12. J Laryngol Otol. 2011. PMID: 21745431 Review.
INTRODUCTION: This article reviews the literature pertaining to bismuth iodoform paraffin paste. OVERVIEW: Bismuth iodoform paraffin paste is used in most otolaryngology departments on a daily basis. Questions about its properties are common in postgraduate otolaryn …
INTRODUCTION: This article reviews the literature pertaining to bismuth iodoform paraffin paste. OVERVIEW: Bismuth iodoform pa …
Safety of bismuth.
Playford RJ, Macdonald CE. Playford RJ, et al. Aliment Pharmacol Ther. 1996 Dec;10(6):1035-6. doi: 10.1046/j.1365-2036.1996.d01-764.x. Aliment Pharmacol Ther. 1996. PMID: 8971308 No abstract available.
Biological Activities of Bismuth Compounds: An Overview of the New Findings and the Old Challenges Not Yet Overcome.
Rosário JDS, Moreira FH, Rosa LHF, Guerra W, Silva-Caldeira PP. Rosário JDS, et al. Molecules. 2023 Aug 7;28(15):5921. doi: 10.3390/molecules28155921. Molecules. 2023. PMID: 37570891 Free PMC article. Review.
Bismuth-based drugs have been used primarily to treat ulcers caused by Helicobacter pylori and other gastrointestinal ailments. ...In this way, we hope this review provides a fertile ground for rationalizing new bismuth-based drugs....
Bismuth-based drugs have been used primarily to treat ulcers caused by Helicobacter pylori and other gastrointestinal ailments. ...In …
[Bismuth encephalopathy].
Krüger G. Krüger G. Fortschr Neurol Psychiatr. 1984 Jan;52(1):24-31. doi: 10.1055/s-2007-1001998. Fortschr Neurol Psychiatr. 1984. PMID: 6698481 German.
During the last years a new disease entity was predominantly observed in France and Australia, which was named bismuth encephalopathy, on account of high bismuth blood levels associated with a characteristic neuropsychiatric clinical picture. ...The typical features …
During the last years a new disease entity was predominantly observed in France and Australia, which was named bismuth encephalopathy …
Recent advances in bioinorganic chemistry of bismuth.
Li H, Sun H. Li H, et al. Curr Opin Chem Biol. 2012 Apr;16(1-2):74-83. doi: 10.1016/j.cbpa.2012.01.006. Epub 2012 Feb 7. Curr Opin Chem Biol. 2012. PMID: 22322154 Free PMC article. Review.
Recent structural characterization of bismuth drugs provides an insight into assembly and pharmacokinetic pathway of the drugs. Mining potential protein targets inside the pathogen via metallomic/metalloproteomic approach and further characterization on the interactions of …
Recent structural characterization of bismuth drugs provides an insight into assembly and pharmacokinetic pathway of the drugs. Minin …
Pharmacokinetics and toxicity of bismuth compounds.
Slikkerveer A, de Wolff FA. Slikkerveer A, et al. Med Toxicol Adverse Drug Exp. 1989 Sep-Oct;4(5):303-23. doi: 10.1007/BF03259915. Med Toxicol Adverse Drug Exp. 1989. PMID: 2682129 Review.
Whether hepatitis is a side effect, however, is open to dispute. Each of these adverse effects is associated with certain bismuth compounds. Bismuth encephalopathy occurred in France as an epidemic of toxicity and was associated with the intake of inorganic salts in …
Whether hepatitis is a side effect, however, is open to dispute. Each of these adverse effects is associated with certain bismuth com …
High-Throughput Strategies for the Design, Discovery, and Analysis of Bismuth-Based Photocatalysts.
Prabhakar Vattikuti SV, Zeng J, Ramaraghavulu R, Shim J, Mauger A, Julien CM. Prabhakar Vattikuti SV, et al. Int J Mol Sci. 2022 Dec 30;24(1):663. doi: 10.3390/ijms24010663. Int J Mol Sci. 2022. PMID: 36614112 Free PMC article. Review.
Bismuth-based nanostructures (BBNs) have attracted extensive research attention due to their tremendous development in the fields of photocatalysis and electro-catalysis. ...Based on recent reports, current challenges and future directions for designing and developing b …
Bismuth-based nanostructures (BBNs) have attracted extensive research attention due to their tremendous development in the fields of …
[Bismuth. An old medicine of current interest].
Qvigstad G, Waldum HL. Qvigstad G, et al. Tidsskr Nor Laegeforen. 1995 Apr 30;115(11):1353-7. Tidsskr Nor Laegeforen. 1995. PMID: 7770830 Review. Norwegian.
Less than 1% of ingested bismuth is absorbed in the gastrointestinal tract and is excreted in the urine. ...Triple treatment with bismuth, tetracycline and metronidazole eradicates H pylori in 95% of patients. ...
Less than 1% of ingested bismuth is absorbed in the gastrointestinal tract and is excreted in the urine. ...Triple treatment with …
18,106 results
You have reached the last available page of results. Please see the User Guide for more information.